RxDoctor Payments Data

Dorothy Rodriguez

Adult Health · Pontiac, MINPI 1043261985

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.0% of the total across 208 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 46 manufacturers, the largest accounting for just 9.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,037, 2.4 times the $847 reported in 2021. Among adult health clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,677in general payments, 2019–2025

Across 208 payments — averaging $27.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ferring Pharmaceuticals Inc.$525
  • Antares Pharma, Inc.$484
  • Sumitomo Pharma America, Inc.$461
  • Coloplast$334
  • Urogen Pharma, Inc.$269
  • Johnson & Johnson$252
  • plus $3K from 40 others

What the payments were for

  • Food & beverage$5,28193%
  • Education$2444%
  • Gifts$1523%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,677 in reported general payments places this provider in the 90th percentile of 527 adult health providers in Michigan.

See all adult health providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron80$63,305
MyrbetriqMirabegron37$25,019
Mirabegron ErMirabegron11$11,087
Tamsulosin Hcl230$4,857
Finasteride78$1,662
Testosterone18$1,387
Tolterodine Tartrate ErTolterodine Tartrate11$1,320
Alfuzosin Hcl ErAlfuzosin Hcl20$810
Testosterone Cypionate19$561
Solifenacin Succinate19$530
Desmopressin Acetate11$429
Oxybutynin Chloride26$317
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst11$214
Cephalexin39$137
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim31$110

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$461$63,30580 claims
Astellas Pharma US IncMyrbetriq$239$25,01937 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 527 adult health providers in Michigan.

Other adult health in Pontiac

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →